Essec\Faculty\Model\Contribution {#2216
#_index: "academ_contributions"
#_id: "2381"
#_source: array:26 [
"id" => "2381"
"slug" => "recurrent-wheezing-in-infants"
"yearMonth" => "2016-04"
"year" => "2016"
"title" => "Recurrent Wheezing in Infants"
"description" => "BELHASSEN, M., DE BLIC, J., LAFOREST, L., LAIGLE, V., CHANUT-VOGEL, C. et DE POUVOURVILLE, G. (2016). Recurrent Wheezing in Infants. <i>Medicine</i>, 95(15)."
"authors" => array:6 [
0 => array:3 [
"name" => "DE POUVOURVILLE Gérard"
"bid" => "B00072308"
"slug" => "de-pouvourville-gerard"
]
1 => array:1 [
"name" => "BELHASSEN M."
]
2 => array:1 [
"name" => "DE BLIC J."
]
3 => array:1 [
"name" => "LAFOREST L."
]
4 => array:1 [
"name" => "LAIGLE V."
]
5 => array:1 [
"name" => "CHANUT-VOGEL C."
]
]
"ouvrage" => ""
"keywords" => []
"updatedAt" => "2021-07-13 14:30:51"
"publicationUrl" => null
"publicationInfo" => array:3 [
"pages" => null
"volume" => "95"
"number" => "15"
]
"type" => array:2 [
"fr" => "Articles"
"en" => "Journal articles"
]
"support_type" => array:2 [
"fr" => "Revue scientifique"
"en" => "Scientific journal"
]
"countries" => array:2 [
"fr" => null
"en" => null
]
"abstract" => array:2 [
"fr" => "Recurrent wheezing (RW) has a significant impact on infants, caregivers, and society, but morbidity and related medical resource utilization (MRU) have not been thoroughly explored. The burden of RW needs to be documented with population-based data. The objective was to assess the characteristics, medical management, and MRU of RW infants identified from national claims data. Infants aged from 6 to 24 months, receiving 2 dispensations of respiratory drugs within 3 months, and presenting a marker of poor control (index date), were selected. During the 6 months after index date, MRU was described in the cohort and among 3 subgroups with more severe RW, defined as 4 dispensations of respiratory drugs, 3 dispensations of oral corticosteroids (OCS), or 1 hospitalization for respiratory symptoms."
"en" => "Recurrent wheezing (RW) has a significant impact on infants, caregivers, and society, but morbidity and related medical resource utilization (MRU) have not been thoroughly explored. The burden of RW needs to be documented with population-based data. The objective was to assess the characteristics, medical management, and MRU of RW infants identified from national claims data. Infants aged from 6 to 24 months, receiving 2 dispensations of respiratory drugs within 3 months, and presenting a marker of poor control (index date), were selected. During the 6 months after index date, MRU was described in the cohort and among 3 subgroups with more severe RW, defined as 4 dispensations of respiratory drugs, 3 dispensations of oral corticosteroids (OCS), or 1 hospitalization for respiratory symptoms."
]
"authors_fields" => array:2 [
"fr" => "Management"
"en" => "Management"
]
"indexedAt" => "2024-12-22T12:21:42.000Z"
"docTitle" => "Recurrent Wheezing in Infants"
"docSurtitle" => "Journal articles"
"authorNames" => "<a href="/cv/de-pouvourville-gerard">DE POUVOURVILLE Gérard</a>, BELHASSEN M., DE BLIC J., LAFOREST L., LAIGLE V., CHANUT-VOGEL C."
"docDescription" => "<span class="document-property-authors">DE POUVOURVILLE Gérard, BELHASSEN M., DE BLIC J., LAFOREST L., LAIGLE V., CHANUT-VOGEL C.</span><br><span class="document-property-authors_fields">Management</span> | <span class="document-property-year">2016</span>"
"keywordList" => ""
"docPreview" => "<b>Recurrent Wheezing in Infants</b><br><span>2016-04 | Journal articles </span>"
"docType" => "research"
"publicationLink" => "<a href="#" target="_blank">Recurrent Wheezing in Infants</a>"
]
+lang: "en"
+"_type": "_doc"
+"_score": 9.029856
+"parent": null
}